Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation.

ABSTRACT:

Objectives

Other than age, diabetes is the largest contributor to overall healthcare costs and reduced life expectancy in Europe. This paper aims to more exactly quantify the net impact of diabetes on different aspects of healthcare provision in hospitals in England, building on previous work that looked at the determinants of outcome in type 1 diabetes (T1DM) and type 2 diabetes (T2DM).

Setting

NHS Digital Hospital Episode Statistics (HES) in England was combined with the National Diabetes Audit (NDA) to provide the total number in practice of people with T1DM/T2DM.

Outcome measures

We compared differences between T1DM/T2DM and non-diabetes individuals in relation to hospital activity and associated cost.

Results

The study captured 90% of hospital activity and

SUBMITTER: Stedman M 

PROVIDER: S-EPMC7223153 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature